1. Home
  2. RGEN vs EXLS Comparison

RGEN vs EXLS Comparison

Compare RGEN & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • EXLS
  • Stock Information
  • Founded
  • RGEN 1981
  • EXLS 1999
  • Country
  • RGEN United States
  • EXLS United States
  • Employees
  • RGEN N/A
  • EXLS N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • EXLS Business Services
  • Sector
  • RGEN Health Care
  • EXLS Consumer Discretionary
  • Exchange
  • RGEN Nasdaq
  • EXLS Nasdaq
  • Market Cap
  • RGEN 8.0B
  • EXLS 7.0B
  • IPO Year
  • RGEN N/A
  • EXLS 2006
  • Fundamental
  • Price
  • RGEN $123.24
  • EXLS $45.53
  • Analyst Decision
  • RGEN Buy
  • EXLS Strong Buy
  • Analyst Count
  • RGEN 12
  • EXLS 8
  • Target Price
  • RGEN $172.67
  • EXLS $49.00
  • AVG Volume (30 Days)
  • RGEN 860.3K
  • EXLS 1.6M
  • Earning Date
  • RGEN 04-29-2025
  • EXLS 04-29-2025
  • Dividend Yield
  • RGEN N/A
  • EXLS N/A
  • EPS Growth
  • RGEN N/A
  • EXLS 21.21
  • EPS
  • RGEN N/A
  • EXLS 1.32
  • Revenue
  • RGEN $650,429,000.00
  • EXLS $1,902,884,000.00
  • Revenue This Year
  • RGEN $12.61
  • EXLS $13.96
  • Revenue Next Year
  • RGEN $15.24
  • EXLS $11.46
  • P/E Ratio
  • RGEN N/A
  • EXLS $34.47
  • Revenue Growth
  • RGEN 4.88
  • EXLS 14.18
  • 52 Week Low
  • RGEN $102.97
  • EXLS $28.59
  • 52 Week High
  • RGEN $182.52
  • EXLS $52.43
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 39.31
  • EXLS 48.99
  • Support Level
  • RGEN $125.31
  • EXLS $43.77
  • Resistance Level
  • RGEN $143.56
  • EXLS $47.07
  • Average True Range (ATR)
  • RGEN 6.86
  • EXLS 1.51
  • MACD
  • RGEN -1.22
  • EXLS 0.13
  • Stochastic Oscillator
  • RGEN 0.54
  • EXLS 40.18

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

Share on Social Networks: